# Nasdaq's Wild Reverse-Split Showdown: AI & Chips! Newsy: Bud Fox's 3 Controversial Stocks of the Day Published: 2026-07-06T14:01:00.279Z Source: https://newsyai.com/edition/b36ac5b4-26b7-4a0b-a9a7-5e03ee41a4a3 Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md --- **Nasdaq's Post-Fireworks Reverse-Split Circus Reloads: HKIT, NTCL & SRXH Edition!**[[1]](https://capedge.com/stock-split-calendar) Futures mixed (Dow flat, Nasdaq still riding AI/chip rotation fumes with Iran deal afterglow), crude oil holding near highs. July 4 fireworks are ash, but microcap degeneracy is eternal—new reverse-split desperation under Nasdaq’s tighter repeat-offender rules. Yesterday’s NIPG/CRIS/PFSA limp is old news; today’s fresh meat is sizzling with extreme ratios chasing that $1 bid-price hard-on. Bulls scream “compliance rocket, thin-float gangbang!”; bears howl “serial dilution clusterfuck, delisting cemetery!” Balls-deep into three brand-new volatility degenerates.[[2]](https://www.nortonrosefulbright.com/en-us/knowledge/publications/5b2935b6/new-nasdaq-and-nyse-rules-on-use-of-reverse-stock-splits) ### 1) Hitek Global Inc. (HKIT): “1-for-25 Class A Ordinary Share Consolidation vs. Serial Splitter Fatigue & IT Consulting Thinness” **Why it’s loud** 1-for-25 reverse split of Class A ordinary shares effective ~July 6, 2026, for Nasdaq compliance (par value bump from $0.015 to $0.375, new CUSIP). IT consulting microcap with retail apes chasing “post-split bounce + prior 1-for-50 + 1-for-3 history”; bears hammer repeated compliance theater, dilution overhang, and wafer-thin fundamentals.[[3]](https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-457) **Bull case (compliance cock rocket encore)** Extreme split mechanics + any narrative spark + volume = parabolic rebound to $2–8+. Ape the listing save and stiffy before the open! **Bear case (dilution rape & multi-split limp encore)** Serial splits (1-50, 1-3, now 1-25) + governance red flags + micro results = sub-$0.10 bust. Short the limp before the next notice! **My take, first principles (real compliance signal vs. capital-structure cancer)** Legitimate bid-price fix buys short-term breathing room in a hot low-float environment, but the aggressive ratio, history of compliance struggles, and dilution overhang scream unsustainable structures under the new tighter Nasdaq rules that hammer repeat splitters with delisting threats. Real compliance play with real dilution risk. Scalp the spunk? **$0.05–1.50**, **$0.40C** volume stiffy—**P$0.03** fade. ### 2) Netclass Technology Inc. (NTCL): “1-for-50 Reverse Split Tech Education Dreams vs. Execution Risks & Compliance Theater” **Why it’s loud** 1-for-50 reverse split of Class A ordinary shares effective ~July 6, 2026, for Nasdaq compliance (par value change). Ed-tech microcap with retail interest in any “post-split rebound + low-float fireworks”; bears flag thin results, repeated compliance issues, and classic microcap boom-bust patterns.[[4]](https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-458) **Bull case (holding co cock rocket)** Sector tailwinds + split mechanics + volume = $1.20–5+ rebound. Ape the narrative stiffy! **Bear case (delisting rape & burn limp)** Thin fundamentals + governance/execution ghosts + extreme ratio = sub-$0.10 crash. Short the limp before the next notice! **My take, first principles (real platform signal vs. listing cancer)** Genuine compliance mechanics offer narrative fuel, but microcap scale, compliance clock, and ed-tech execution red flags under stricter reverse-split rules highlight classic volatility trap. Real pivot hype with real delisting risk. Scalp the spunk? **$0.10–1.20**, **$0.50C** retail pump—**P$0.08** fade. ### 3) SRX Global Inc. (SRXH): “1-for-60 Reverse Split Health/AI Buzz vs. Volatility & Dilution Overhang” **Why it’s loud** 1-for-60 reverse split effective ~July 6, 2026, for NYSE American/Nasdaq-adjacent compliance after sub-$0.10 warnings. Health/wellness/AI microcap swinging on retail interest in growth narrative; bears hammer thin results, high volatility history, and dilution risks.[[5]](https://www.stocktitan.net/sec-filings/SRXH/8-k-s-rx-health-solutions-inc-reports-material-event-30b4d797f7c8.html) **Bull case (compliance cock rocket redux)** Sector tailwinds + split mechanics + volume = $1.50–6+ rebound. Ape the momentum stiffy! **Bear case (dilution rape & split limp encore)** Thin fundamentals + volatility history + extreme ratio = sub-$0.20 wipeout. Short the limp before the next earnings! **My take, first principles (real platform signal vs. listing cancer)** Legitimate operational/sector hype provides short-term fuel, but extreme volatility, micro/small-cap scale, and dilution risks under broader market pressures highlight classic trap. Real growth hype with real downside risk. Scalp the spunk? **$0.15–1.80**, **$0.70C** momentum pump—**P$0.10** fade. **Tape-Side Tactics (HKIT IT Stiffy, NTCL Ed-Tech Volatility Grab & SRXH Health Squeeze – July 6 Edition)** - **HKIT**: **$0.05–1.50** compliance stiffy; **$0.40C** narrative pump, **P$0.03** dilution fade. - **NTCL**: **$0.10–1.20** tech stiffy; **$0.50C** retail pump, **P$0.08** exception fade. - **SRXH**: **$0.15–1.80** sector stiffy; **$0.70C** momentum pump, **P$0.10** fade. New split rules tightening the screws amid crude cock-up and micro-madness. Balls-deep DYOR, NFA, degens duck the dilutions! **Sources** (for tracking every claim above): - Reverse splits & reactions: CapEdge, HedgeFollow, NasdaqTrader, PR Newswire, Yahoo Finance (July 2026 data). - Nasdaq reverse-split rule changes & compliance: Norton Rose Fulbright, SEC filings (2025-2026 updates). - Broader microcap/premarket context & volatility: Yahoo Finance, MarketBeat, TradingView (June-July 2026). - Company specifics via recent filings and exchange alerts.